Table 1.
Cohort demographic
| Overall | Diclofenac group | Antihypertensives TB group | Antihypertensives AAC group | Statins group | |
|---|---|---|---|---|---|
| Characteristics | % (n) | % (n) | % (n) | % (n) | % (n) |
| Recruited number of patients | 100 (32 086) | 22.25 (7140) | 17.98 (5769) | 20.46 (6565) | 39.31 (12 612) |
| Sex | |||||
| Male | 52.98 (16 999) | 49.69 (3548) | 31.20 (1800) | 49.52 (3251) | 66.60 (8400) |
| Female | 47.01 (15 083) | 50.29 (3591) | 68.80 (3969) | 50.46 (3313) | 33.38 (4210) |
| Unknown | 4 | 1 | 0 | 1 | 2 |
| Age | |||||
| 40–44 | 22.0 (7045) | 33.8 (2415) | 20.4 (1179) | 19.1 (1255) | 17.4 (2196) |
| 45–49 | 22.7 (7289) | 26.4 (1886) | 22.4 (1295) | 22.0 (1445) | 21.1 (2663) |
| 50–54 | 26.1 (8367) | 21.1 (1509) | 27.4 (1582) | 27.3 (1794) | 27.6 (3482) |
| 55–59 | 29.2 (9385) | 18.6 (1330) | 29.7 (1713) | 31.5 (2071) | 33.9 (4271) |
| Ethnicity | |||||
| NZ European* | 69.46 (22 287) | 61.3 (4377) | 76.39 (4407) | 69.23 (4545) | 71.03 (8958) |
| Maori | 7.05 (2261) | 14.26 (1018) | 5.91 (341) | 7.75 (509) | 3.12 (393) |
| Pacific Island† | 3.48 (1116) | 8.75 (625) | 1.87 (108) | 2.83 (186) | 1.56 (197) |
| Asian‡ | 5.31 (1703) | 5.04 (360) | 5.23 (302) | 4.90 (322) | 5.70 (719) |
| Others§ | 0.93 (298) | 1.44 (103) | 0.81 (47) | 0.70 (46) | 0.81 (102) |
| Unknown¶ | 4421 | 657 | 564 | 957 | 2243 |
*NZ European=NZ European, Other European, European NFD.
†Pacific Island=Cook Island, Fijian, Niuean, Samoan, Tokelauan, Tongan, Pacific Island, Other Pacific Island.
‡Asian=Asian, Chinese, Other Asian, Indian, Southeast Asian.
§Others=African, Latin American/Hispanic, Middle Eastern, other, other ethnicity.
¶Unknown=other, other ethnicity, not stated, don't know, refused to answer, response unidentifiable.
AAC, ACE inhibitors, angiotensin II receptor blockers, calcium channel blockers; TB, thiazides and β-blockers.